It is shown that sustained Notch induced signals are required to seal the commitment of TCR ab /CD3 expressing cells into the TCR ab T cell lineage, which otherwise develop into cells phenotypically resembling NK cells or NKT cells.
Adoptive T-cell therapies using chimeric antigen receptors (CARs) or engineered T-cell receptors (TCRs) have transformed cancer treatment but remain limited by poor persistence and progressive T-cell exhaustion. Manufacturing strategies that promote memory T-cell formation may improve therapeutic durability. Here we...
Alexandra Boix de Jesus, Hy B. Dao, Anthony Imani et al.· Frontiers in Immunology· 0 citations
It is shown that the absence of Notch signal causes severe CD8+ T cell exhaustion during chronic LCMV infection and demonstrated that Notch signaling is essential to promote the differentiation of Tex progenitors into Tex effector-like cells.
Dave Maurice De Sousa, Salix Boulet, F. Duval et al.· bioRxiv· 0 citations
Early thymic progenitors (ETPs) retain the potential for alternative fates but commit to the T-cell lineage as they progress through the CD4−CD8− double-negative (DN) thymocyte stages early in T-cell development. Current evidence suggests that T-lineage commitment occurs during the transition from the DN2a to DN2b stag...
Dhruti Parikh, Karen Gu, Sara Tomei et al.· Frontiers in Immunology· 0 citations
Successful cellular immunotherapy for cancer utilising cytotoxic T lymphocytes (CTL) requires efficient expansion while maintaining effector function. Understanding how CTL expansion and function are regulated during the cell preparation process is thus important. Here, we show that T cell-specific deletion of Prmt7 us...
Nivine Srour, Kai-Xiu Luo, D. Allard et al.· Nature Communications· 1 citation
Classically, B and T lymphocytes are regarded as distinct lineages that can be readily distinguished by the receptors expressed on their surface. However, our recent study established that peritoneal B1 cells serve as precursors for extrathymic T cells through a TCR+CD19+ double-positive (DP) intermediate. To investiga...
Jeong-Eun Seon, Su-Min Yee, Sung-Gwon Lee et al.· Biochemical and Biophysical...· 0 citations
Effector B cell responses in solid malignancies are associated favorable response to immunotherapy. B cells can amplify anti-tumor immune responses via antibody production, antigen presentation, and pro-inflammatory cytokine release; yet B cells in cancer patients and tumor-bearing mice often fail to support these fu...
Y. Pylayeva-Gupta· Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.